Actively Recruiting
Ultrasound-Guided Percutaneous Neuromodulation on the Superior Gluteal Nerve in Patients With Greater Trochanteric Pain Syndrome: A Pilot Study
Led by Universidad de Zaragoza · Updated on 2025-06-02
50
Participants Needed
1
Research Sites
66 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Greater Trochanteric Pain Syndrome (GTPS) predominantly affects women, with an annual incidence of 1.8 to 5.6 per 1000 individuals and a prevalence ratio of 4:1 compared to men. It is characterized by lateral pain in the greater trochanter region, particularly during palpation, prolonged sitting, and physical activity. Conservative treatments, such as radial shockwave therapy and therapeutic exercises, are effective but slow, and some patients eventually require surgery. Ultrasound-guided percutaneous neuromodulation, targeting the superior gluteal nerve, has emerged as a promising alternative to improve GTPS outcomes. This technique aims to normalize motor response and reduce pain more rapidly than conventional therapies. Integrating neuromodulation could accelerate recovery, enhancing both pain relief and tendon functionality. This study aims to explore the effectiveness of this technique as an adjunct to conventional treatments, aiming for faster symptom improvement and better long-term adherence.
CONDITIONS
Official Title
Ultrasound-Guided Percutaneous Neuromodulation on the Superior Gluteal Nerve in Patients With Greater Trochanteric Pain Syndrome: A Pilot Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Suffering from Greater Trochanteric Pain Syndrome (GTPS)
- Local pain upon palpation of the greater trochanter area
- Pain in the greater trochanter region lasting more than three months
- Over 18 years of age
- Pain when bearing weight on the affected trochanter
- Pain that impairs resisted hip abduction functionality
You will not qualify if you...
- Radiological evidence of pathology in the hip or knee joints
- Blood coagulation disorders
- Use of oral anticoagulants
- Presence of infections
- History of disc or hip surgery
- Presence of dysplasia, deformities, or sciatica
- History of vascular, neurological, or neoplastic diseases
- Contraindications for ultrasound-guided percutaneous neuromodulation including belenophobia, pregnancy, pacemakers, epilepsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Zaragoza
Zaragoza, Zaragoza, Spain, 50009
Actively Recruiting
Research Team
A
Alberto Carcasona, Physiotherapist
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here